Have a personal or library account? Click to login
Immunopathogenic Treatment Options for Psoriasis Patients Under a Restrictive Reimbursement Environment Cover

Immunopathogenic Treatment Options for Psoriasis Patients Under a Restrictive Reimbursement Environment

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
Volume 75 (2021): Issue 3 (June 2021)
By: Ilona Hartmane,  Iveta Ivdra,  Ingmārs Mikažāns and  Vanda Bondare-Ansberga  
Open Access
|Jul 2021

Authors

Ilona Hartmane

ilona.hartmane@rsu.lv

Clinical Centre of Skin and Sexually Transmitted Diseases, Latvia
Department of Dermatology, Rīga Stradiņš University, Latvia

Iveta Ivdra

Clinical Centre of Skin and Sexually Transmitted Diseases, Latvia
Department of Dermatology, Rīga Stradiņš University, Latvia

Ingmārs Mikažāns

Clinical Centre of Skin and Sexually Transmitted Diseases, Latvia
Department of Dermatology, Rīga Stradiņš University, Latvia

Vanda Bondare-Ansberga

Clinical Centre of Skin and Sexually Transmitted Diseases, Latvia
DOI: https://doi.org/10.2478/prolas-2021-0025 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Journal RSS Feed
Language: English
Page range: 158 - 166
Submitted on: Jun 11, 2020
Accepted on: Mar 1, 2021
Published on: Jul 22, 2021
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
autoimmune skin disorder,
biological therapy,
state compensation,
Baltic
Related subjects:
General interest,
Mathematics,
General mathematics

© 2021 Ilona Hartmane, Iveta Ivdra, Ingmārs Mikažāns, Vanda Bondare-Ansberga, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 75 (2021): Issue 3 (June 2021)Next article